BACKGROUND: -agonists for symptom relief and have poor adherence to maintenance therapy. Another approach might be for patients to receive a fast-acting reliever plus an inhaled glucocorticoid component on an as-needed basis to address symptoms and exacerbation risk. METHODS: We conducted a 52-week,...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!